Literature DB >> 9794448

Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis.

C S Constantinescu1, M Wysocka, B Hilliard, E S Ventura, E Lavi, G Trinchieri, A Rostami.   

Abstract

Immunization of (PL/J x SJL/J)F1 mice with myelin basic protein (MBP) induces relapsing experimental autoimmune encephalomyelitis (EAE). Relapses occur 7 to 10 days after recovery from the initial paralysis. Staphylococcal enterotoxins (SE) A or B, administered after recovery from the initial paralysis, induce immediate relapses. IL-12 is involved in the induction of EAE. Here, we show that SEA and SEB induce IL-12 in splenocytes from (PL/J x SJL/J)F1 mice in vitro and increase the level of IL-12 in the sera of mice treated with these superantigens. IL-12 administration mimics SE in inducing spontaneous relapses and in enhancing the severity and frequency of spontaneous relapses. IL-12 neutralization blocks SE-induced and subsequent relapses of EAE, and, when instituted after recovery from the initial attack, prevents spontaneous relapse. This is the first report of prevention of relapses of EAE with anti-IL-12 Ab, an approach which may prove useful in the prevention of exacerbations in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794448

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells.

Authors:  E M Shevach; J T Chang; B M Segal
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.

Authors:  T Chitnis; N Najafian; C Benou; A D Salama; M J Grusby; M H Sayegh; S J Khoury
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 3.  Cytokine-based immunointervention in the treatment of autoimmune diseases.

Authors:  L Adorini
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 4.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 5.  Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  Xu Zhang; Raymond Hupperts; Marc De Baets
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease.

Authors:  F Nicoletti; R Di Marco; P Zaccone; G Magro; M Di Mauro; S Grasso; P L Meroni
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

7.  IL-17-producing T cells can augment autoantibody-induced arthritis.

Authors:  Jonathan P Jacobs; Hsin-Jung Wu; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

8.  Hunger-promoting hypothalamic neurons modulate effector and regulatory T-cell responses.

Authors:  Giuseppe Matarese; Claudio Procaccini; Ciro Menale; Jae Geun Kim; Jung Dae Kim; Sabrina Diano; Nadia Diano; Veronica De Rosa; Marcelo O Dietrich; Tamas L Horvath
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 9.  Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines.

Authors:  Bhanu P Pappu; Pornpimon Angkasekwinai; Chen Dong
Journal:  Pharmacol Ther       Date:  2008-01-19       Impact factor: 12.310

Review 10.  Barrier immunity and IL-17.

Authors:  Benjamin R Marks; Joe Craft
Journal:  Semin Immunol       Date:  2009-04-21       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.